Intellectual Property (IP) developed by the Princeton Plasma Physics laboratory is typically held and licensed by Princeton University for the Laboratory. A licensing agreement typically provides commercialization rights to patented and/or copyrighted IP developed at Princeton Plasma Physics Laboratory. Due to the unique set of laws and policies governing the licensing of federally funded research and DOE policies regarding intellectual property, licensing agreements for technology developed at DOE Laboratories have some provisions that may not be present in a license agreement between private entities, including march-in-rights, government use rights, and indemnification policies.
Typical financial and milestone terms present in a commercial license include:
• An issue fee, which is non-refundable and due upon execution of the agreement
• A running royalty, which is most commonly based on a percentage of sales
• A minimum annual royalty
• Other financial terms appropriate to the technology and market, such as milestone payments and patent cost reimbursements
• Equity ownership terms which may be negotiated in some cases in lieu of cash payments
• Milestone commitments for development (e.g. alpha & beta products) and introduction of commercial product in marketplace
Licenses may be exclusive for a particular field of use or geographic region, or non-exclusive.
Most of the technologies available for licensing will require additional development before they are commercially viable. An Option Agreement is available that protects an entity’s right to license a technology at a future time. Option Agreements are generally available for a limited time period. In some cases it may be possible to extend the Option Agreement if sufficient milestones towards making the technology commercially-viable have been met. See the PPPL Patent Database and PPPL Disclosure Database of technologies available for licensing.